drugset / Trial / NCT02926235

Trial of Essential Amino Acid Supplementation in Protein Deficient Patients Following Total Knee Arthroplasty

NCT02926235

Phase 4 Terminated 50 enrolled Hospital for Special Surgery, New York
RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this trial is to assess the efficacy of essential amino acids (EAA) on muscle atrophy and malnutrition compared to a placebo in patients following a total knee arthroplasty. The investigators specific objectives included analysis of (1) muscle strength, (2) change in malnutrition, (3) perioperative complications (4) physical activity.

Timeline

Start
2016-04
Primary completion
2022-05-14
Completion
2022-05-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Amino Acid Other / unclassified 20 g

Indications